Search research articles
Contact Us
Filters
Showing results (51-60 of 93) with videos related to
Page
of 10
Sort By:
Plos One
|
July 12, 2007
Optimization of energy-consuming pathways towards rapid growth in HPV-transformed cells
Sarit Mizrachy-Schwartz, Nataly Kravchenko-Balasha, Hannah Ben-Bassat, et al.
Analytical Biochemistry
|
December 27, 2011
Studying protein-peptide interactions using benzophenone units: a case study of protein kinase B/Akt and its inhibitor PTR6154
Yftah Tal-Gan, Shirly Naveh, Shoshana Klein, et al.
FEBS Letters
|
February 28, 2003
The pp60c-Src inhibitor PP1 is non-competitive against ATP
Rotem Karni, Sarit Mizrachi, Ella Reiss-Sklan, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
March 3, 2010
Novel method for the synthesis of urea backbone cyclic peptides using new Alloc-protected glycine building units
Mattan Hurevich, Yftah Tal-Gan, Shoshana Klein, et al.
IUBMB Life
|
February 25, 2012
PolyIC GE11 polyplex inhibits EGFR-overexpressing tumors
Galith Abourbeh, Alexei Shir, Eyal Mishani, et al.
Pharmaceutical Research
|
August 10, 2010
Poly(I:C)-mediated tumor growth suppression in EGF-receptor overexpressing tumors using EGF-polyethylene glycol-linear polyethylenimine as carrier
David Schaffert, Melinda Kiss, Wolfgang Rödl, et al.
Experimental and Molecular Pathology
|
June 1, 2005
The effect of tyrphostin AG-556 on intimal thickening in a mouse model of arterial injury
Jacob George, Iris Barshack, Pnina Keren, et al.
Protein Expression and Purification
|
April 2, 2005
Expression and purification of active PKB kinase from Escherichia coli
Shoshana Klein, Tamar Geiger, Inbal Linchevski, et al.
Bioorganic & Medicinal Chemistry
|
June 10, 2004
Novel iodine-124 labeled EGFR inhibitors as potential PET agents for molecular imaging in cancer
Mazal Shaul, Galith Abourbeh, Orit Jacobson, et al.
Cancer Letters
|
March 17, 2006
Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors)
Yumiko Hirokawa, Alexander Levitzki, Guillaume Lessene, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 93) with videos related to
Sort By:
Page
of 10
Plos One
|
July 12, 2007
Optimization of energy-consuming pathways towards rapid growth in HPV-transformed cells
Sarit Mizrachy-Schwartz, Nataly Kravchenko-Balasha, Hannah Ben-Bassat, et al.
Analytical Biochemistry
|
December 27, 2011
Studying protein-peptide interactions using benzophenone units: a case study of protein kinase B/Akt and its inhibitor PTR6154
Yftah Tal-Gan, Shirly Naveh, Shoshana Klein, et al.
FEBS Letters
|
February 28, 2003
The pp60c-Src inhibitor PP1 is non-competitive against ATP
Rotem Karni, Sarit Mizrachi, Ella Reiss-Sklan, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
March 3, 2010
Novel method for the synthesis of urea backbone cyclic peptides using new Alloc-protected glycine building units
Mattan Hurevich, Yftah Tal-Gan, Shoshana Klein, et al.
IUBMB Life
|
February 25, 2012
PolyIC GE11 polyplex inhibits EGFR-overexpressing tumors
Galith Abourbeh, Alexei Shir, Eyal Mishani, et al.
Pharmaceutical Research
|
August 10, 2010
Poly(I:C)-mediated tumor growth suppression in EGF-receptor overexpressing tumors using EGF-polyethylene glycol-linear polyethylenimine as carrier
David Schaffert, Melinda Kiss, Wolfgang Rödl, et al.
Experimental and Molecular Pathology
|
June 1, 2005
The effect of tyrphostin AG-556 on intimal thickening in a mouse model of arterial injury
Jacob George, Iris Barshack, Pnina Keren, et al.
Protein Expression and Purification
|
April 2, 2005
Expression and purification of active PKB kinase from Escherichia coli
Shoshana Klein, Tamar Geiger, Inbal Linchevski, et al.
Bioorganic & Medicinal Chemistry
|
June 10, 2004
Novel iodine-124 labeled EGFR inhibitors as potential PET agents for molecular imaging in cancer
Mazal Shaul, Galith Abourbeh, Orit Jacobson, et al.
Cancer Letters
|
March 17, 2006
Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors)
Yumiko Hirokawa, Alexander Levitzki, Guillaume Lessene, et al.
Page
of 10